Skip to content

3D-MFR in individuals with Cervical Spondylosis

Effectiveness of 3D-MFR on Proprioception, Pain, ROM and Function in Cervical Spondylosis: A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072200
Enrollment
36
Registered
2024-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

Intervention1: 3D-MFR + Conventional Treatment: 3D MFR along with Conventional Treatment will be given for 2 Weeks alternate days, 6 sessions in total. Control Intervention1: Sham MFR+ Conventional Tr

Sponsors

KLE Academy of Higher Education and Research Nehru Nagar Belagavi Karnataka India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants: 1. of all gender aged between 25-65 years diagnosed radiologically with cervical spondylosis 2. who report a pain intensity more than 3cm on visual analogue scale 3.  willing to participate in the study

Exclusion criteria

Exclusion criteria: Participants with history of: 1. psychological deficits hindering co-operation with treatment 2. neurological deficits (loss of sensations, paralysis) 3. active inflammatory conditions (rheumatic arthritis, ankylosing    spondylitis) 4.Contraindications to 3D-MFR like, Open wounds, previous neck surgery, cervical spine fracture, recent trauma, severe skin diseases like dermatitis

Design outcomes

Primary

MeasureTime frame
Neck proprioception using Joint repositioning error test, Pain using Visual analogue scale , Range of motion with Goniometer and Function using Neck disability indexTimepoint: At baseline after 2 weeks of treatment

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactAarti Welling

KAHER Institute of Physiotherapy

aartiwell88@gmail.com9448814569

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026